Margherita Zen

19PUBLICATIONS
122CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Humoural immunology and immunochemistryMajor global burdens of diseaseBiomechanicsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 03, 2026
Belimumab outperforms placebo for attainment of modified DORIS remission and LLDAS without the glucocorticoid component: a post hoc analysis of five phase III SLE trials.

|May 04, 2026
Efficacy of belimumab in patients with SLE and haematological manifestations: retrospective analysis from the BeRLiSS 2.0 cohort.

|Mar 24, 2026
Prevalence, incidence, mortality and causes of death in a large cohort of patients with rheumatoid arthritis: an Italian population-based study.

Anna Giorgia Osele, Margherita Zen, Laura Salmaso

|Feb 09, 2026
Fracture risk tools performance and potential use in systemic lupus erythematosus.

Federico Aldegheri, Denise Rotta, Isotta Galvagni

|Dec 19, 2025
Safety of JAK inhibitors versus other biologic therapies following anti-TNF failure in patients with rheumatoid arthritis.

Lorenzo Di Luozzo, Mariangela Salvato, Francesca Frizzera

|Nov 17, 2025
The impact of glucocorticoids on the efficacy of JAK inhibitors or non-TNF-targeted biologics in RA.

Mariangela Salvato, Benedetta Salvatori, Francesca Frizzera

Pageof 4

Frequent Collaborators

14 joint publications

Andrea Doria

7 joint publications

Alessandro Giollo

4 joint publications

Mariele Gatto

4 joint publications

Matteo Piga